Home » Market News » DirectorsTalk Highlights » Kim Kardashian tests positive for lupus & RA
Immupharma Plc

Kim Kardashian tests positive for lupus & RA

Things got pretty intense on Sunday’s episode of Keeping Up with the Kardashians after Kim Kardashian revealed that she’s been feeling…off lately.

At the end of the episode, Kim’s doctor called to say that her “antibodies are positive” for rheumatoid arthritis and lupus, an autoimmune disease that causes inflammation in tissues and organs.

Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.